Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Brace Pharma Capital

Brace Pharma Capital
VC INVESTOR TYPE
Active STATUS
6 PROFESSIONALS
19 INVESTMENTS
11 PORTFOLIO
4 EXITS
Description

Founded in 2013, Brace Pharma Capital is a strategic venture arm of EMS Pharmaceutical Company, based in Rockville, Maryland. The firm seeks to invest in innovative, life-changing therapies for diseases with a high degree of unmet medical need and insufficient treatment options. The firm also has an additional office in Cambridge, Massachusetts.

Investor Status
Actively Seeking New Investments
Year Founded
2013
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
  • 155 Gibbs Street
  • Suite 406
  • Rockville, MD 20850
  • United States

+1 (240) 000-0000

Brace Pharma Capital Investments (19)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
ReViral 01-Aug-2018 Early Stage VC 0000 Drug Discovery Clinical Trials - Phase 2
000000 00000000000 10-Jul-2018 00000 00000 0000 Biotechnology Clinical Trials - Phase 1 0000000 0000000
000000000 00000000 26-Jun-2018 00000 00000 00000 Biotechnology Generating Revenue/Not Profitable
0000000 02-Feb-2018 00000 00000 000.00 Biotechnology Clinical Trials - Phase 2
000000 00000000000 24-Jan-2018 00000 00000 000.00 Biotechnology Clinical Trials - Phase 1 0000000 0000000
0000000 0000000000 13-Feb-2017 0000 000.00 Biotechnology Profitable
0000000 0000000000 05-Jan-2017 00000 00000 0000 Biotechnology Generating Revenue 0000 00000
0000000 0000000000 31-Oct-2016 00000 00000 0000 Biotechnology Profitable
F2G 20-Jun-2016 Later Stage VC 0000 Drug Discovery Clinical Trials - Phase 2
Zymeworks 08-Jan-2016 Mezzanine 000.00 Biotechnology Generating Revenue/Not Profitable
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Brace Pharma Capital’s full profile, request a free trial.

Brace Pharma Capital Exits (4)

Company Name Exit Date Exit Type Exit Size Status Buyers
Precision BioSciences 28-Mar-2019 IPO 00000 Completed
0000000 21-Jun-2018 000 00000 Completed
UNUM Therapeutics 29-Mar-2018 IPO 000.00 Completed
Zymeworks 28-Apr-2017 IPO 0000 Completed
To view this investor’s complete exits history, request access »

Brace Pharma Capital Team (13)

Name Title Deals Funds Boards Office Contact
Info
Jorge Costa Ph.D Founding Director & Scientific Advisor Cambridge, MA
Todd Brady Director of Finance & Investments 0 0 0 Rockville, MD
Daniel Salazar Ph.D Vice President, Clinical & Regulatory Rockville, MD
Samuel Broder MD Medical Advisor and Scientific Advisory Board 0 0 Cambridge, MA
Eric Kandel MD Member of Scientific Advisory Board Cambridge, MA

2 Former Team Members

You’re viewing 5 of 13 team members. Get the full list »